Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis.

Stoffel A, Chaurushiya M, Singh B, Levine AJ.

Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9079-84. Epub 2004 Jun 7.

2.
3.
4.
5.

Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma.

Hosokawa Y, Seto M.

Int J Hematol. 2004 Oct;80(3):215-23. Review.

PMID:
15540895
6.

Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.

Rosebeck S, Lucas PC, McAllister-Lucas LM.

Future Oncol. 2011 May;7(5):613-7. doi: 10.2217/fon.11.35. Review.

7.

MALT lymphoma: many roads lead to nuclear factor-κb activation.

Du MQ.

Histopathology. 2011 Jan;58(1):26-38. doi: 10.1111/j.1365-2559.2010.03699.x. Review.

PMID:
21261681
8.
9.

API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.

Rosebeck S, Lim MS, Elenitoba-Johnson KS, McAllister-Lucas LM, Lucas PC.

World J Biol Chem. 2016 Feb 26;7(1):128-37. doi: 10.4331/wjbc.v7.i1.128. Review.

10.

Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.

Nakamura T, Inagaki H, Seto M, Nakamura S.

J Gastroenterol. 2003;38(10):921-9. Review.

PMID:
14614598
11.

Update on MALT lymphomas.

Isaacson PG.

Best Pract Res Clin Haematol. 2005 Mar;18(1):57-68. Review.

PMID:
15694184
12.

Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling.

Zhang Y, Wei Z, Li J, Liu P.

Sci China Life Sci. 2015 Dec;58(12):1246-55. doi: 10.1007/s11427-015-4977-2. Epub 2015 Nov 26. Review.

PMID:
26612043
13.

The origin and targeting of mucosa-associated lymphoid tissue lymphomas.

Martinez-Climent JA.

Curr Opin Hematol. 2014 Jul;21(4):309-19. doi: 10.1097/MOH.0000000000000051. Review.

PMID:
24867288
14.

Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.

Nagel D, Vincendeau M, Eitelhuber AC, Krappmann D.

Oncogene. 2014 Dec 11;33(50):5655-65. doi: 10.1038/onc.2013.565. Epub 2014 Jan 27. Review.

PMID:
24469030
15.

MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism.

Du MQ.

Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):13-23. doi: 10.1016/j.beha.2016.09.002. Epub 2016 Nov 4. Review.

PMID:
28288707
16.

Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?

Kingeter LM, Schaefer BC.

Cell Signal. 2010 Jan;22(1):9-22. doi: 10.1016/j.cellsig.2009.09.033. Epub 2009 Sep 19. Review.

17.

MALT lymphoma: A paradigm of NF-κB dysregulation.

Du MQ.

Semin Cancer Biol. 2016 Aug;39:49-60. doi: 10.1016/j.semcancer.2016.07.003. Epub 2016 Jul 21. Review.

PMID:
27452667
18.

Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect.

Johnson RF, Perkins ND.

Trends Biochem Sci. 2012 Aug;37(8):317-24. doi: 10.1016/j.tibs.2012.04.002. Epub 2012 May 23. Review.

PMID:
22626470
19.

[Mucosa-associated lymphoid tissue lymphoma].

Gong LP, Zheng J, Gao ZF.

Zhonghua Bing Li Xue Za Zhi. 2006 Apr;35(4):240-3. Review. Chinese. No abstract available.

PMID:
16776985
20.

Mechanisms of NF-κB deregulation in lymphoid malignancies.

Krappmann D, Vincendeau M.

Semin Cancer Biol. 2016 Aug;39:3-14. doi: 10.1016/j.semcancer.2016.05.002. Epub 2016 Jun 2. Review.

PMID:
27262792

Supplemental Content

Support Center